Zobrazeno 1 - 10 of 44 pro vyhledávání: '"H.L.M. Brus"'
1
Implementation of a treat-to-target strategy in very early rheumatoid arthritis: Results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study
Autor: Cees J. Haagsma, H.L.M. Brus, Marcel D. Posthumus, Monique Hoekstra, Mart A F J van de Laar, Piet L. C. M. van Riel, Hillechiena H. Kuper, M. Vermeer
Publikováno v: Arthritis & Rheumatism. 63:2865-2872
Objective Clinical remission is the ultimate therapeutic goal in rheumatoid arthritis (RA). Although clinical trials have proven this to be a realistic goal, the concept of targeting at remission has not yet been implemented. The objective of this st
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ac112d1a168e23dc42391af8ea0b580b
https://doi.org/10.1002/art.30494
Zobrazit plný text záznamu
2
Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice
Autor: H.L.M. Brus, T.L.Th.A. Jansen, H.H. Kuper, Henk Visser, M.A.F.J. van de Laar, A.A. den Broeder, Wietske Kievit, M. Blom, P.L.C.M. van Riel
Publikováno v: Arthritis & Rheumatism-Arthritis Care & Research, 62, 1335-41
Arthritis care & research, 62(9), 1335-1341. Wiley
Arthritis & Rheumatism-Arthritis Care & Research, 62, 9, pp. 1335-41
Contains fulltext : 88603.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To describe the frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in the treatment of rheumatoid arthritis (RA) in daily clinical p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::739a82111b1690522ce06b7bda9cf17d
https://doi.org/10.1002/acr.20211
Zobrazit plný text záznamu
3
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies
Autor: H.H. Kuper, T.L.Th.A. Jansen, J. Fransen, H.L.M. Brus, Eddy M. M. Adang, P C L M Van Riel, C.M.A. de Gendt, M.A.F.J. van de Laar, D. J. R. A. M. De Rooij, Wietske Kievit
Publikováno v: Annals of the Rheumatic Diseases, 68, 844-9
Annals of the rheumatic diseases, 68(6). BMJ Publishing Group
Annals of the Rheumatic Diseases, 68, 6, pp. 844-9
Contains fulltext : 80792.pdf (Publisher’s version ) (Closed access) OBJECTIVE: To study the adherence of rheumatologists to the Dutch guidelines for anti-tumour necrosis factor alpha (TNF-alpha) treatment. The secondary objective was to evaluate a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bdef0b5275cbb665919b8be6712d305
https://hdl.handle.net/2066/80792
Zobrazit plný text záznamu
4
The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis
Autor: Piet L. C. M. van Riel, Carla M.A. De Gendt, T.L.Th.A. Jansen, Mart A F J van de Laar, Ina H. Kuper, M. Blom, Jaap Fransen, H.L.M. Brus, Alfons A den Broeder, Wietske Kievit
Publikováno v: The Journal of Rheumatology, 36, 2171-7
The Journal of Rheumatology, 36, 10, pp. 2171-7
Rheumatology, 36(10), 2171-7. Oxford University Press
Objective.To investigate whether the reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent influences the effect of a second TNF blocking agent.Methods.Data were used from 2 Dutch registries including patients with rheuma
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74614bee0eea8d8f23ddc61a6220be4c
https://doi.org/10.3899/jrheum.090054
Zobrazit plný text záznamu
5
Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors
Autor: Jaap Fransen, Lidy Hendriks, Piet L. C. M. van Riel, Annemarie L M A Braakman-Jansen, Wietske Kievit, Mart A F J van de Laar, H.L.M. Brus, Sofie H. M. Manders
Publikováno v: The Journal of Rheumatology, 41, 7, pp. 1263-9
The Journal of Rheumatology, 41, 1263-9
Journal of rheumatology, 41(7), 1263-1269. Journal of Rheumatology
Objective.Reduced work participation (WP) is a common problem for patients with rheumatoid arthritis (RA) and generates high costs for society. Therefore, it is important to explore determinants of WP at the start of tumor necrosis factor inhibitor (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb53de3da0fc0d75c13dac7225bae7b4
https://hdl.handle.net/2066/137760
Zobrazit plný text záznamu
6
Coordinated individual education with an arthritis passport for patients with rheumatoid arthritis
Autor: Oene Wiegman, Erik Taal, H.L.M. Brus, R Riemsma, Johannes J. Rasker
Publikováno v: Scopus-Elsevier
Objective: To evaluate the effects of a program for individual education in combination with the use of an arthritis passport. - Methods: We studied 3 groups of patients with rheumatoid arthritis. The first experimental group received educational mat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17cbacc8874e7bae5a63d15a2d3511c2
https://doi.org/10.1002/art.1790100405
Zobrazit plný text záznamu
7
Development of a brief observation method for measuring joint protective behaviors
Autor: Frits G. J. Oosterveld, Johannes J. Rasker, Annemarie van Bussel, H.L.M. Brus, Martin A.F.J. van de Laar
Publikováno v: Journal of occupational rehabilitation, 7(3), 167-172. Springer
Ergonomic measures (joint protection, energy conservation and the use of devices) are part of basic treatment in rheumatoid arthritis (RA). It is of increasing importance that Health Care is based on evidence. Therefore, attention should be paid to t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84b55cbd4ef56b8d47781a17564f6167
https://doi.org/10.1007/bf02767362
Zobrazit plný text záznamu
8
Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
Autor: Nella M. Houtman, H.L.M. Brus, Jaap Fransen, Ellen A J Dutmer, Piet L. C. M. van Riel, Sanne A. A. van Dartel, Wietske Kievit, Mart A F J van de Laar
Publikováno v: Rheumatology, 52, 6, pp. 1052-7
Rheumatology, 52(6), 1052-1057. Oxford University Press
Rheumatology, 52, 1052-7
Item does not contain fulltext Objective. The use of TNF inhibitors leads to an increased risk of serious infections in RA. Predicting this risk would facilitate the prevention of serious infections. The objective of this study was to identify which
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1aaaeeb9d82c9685044948ed73db97
https://hdl.handle.net/2066/117464
Zobrazit plný text záznamu
9
The provisional ACR/EULAR definition of remission in RA: a comment on the patient global assessment criterion
Autor: Henriette Baan, Marloes Vermeer, M.D. Posthumus, Mart A F J van de Laar, H.L.M. Brus, Piet L. C. M. van Riel, Arie E. van der Bijl, Hillechiena H. Kuper
Publikováno v: Rheumatology, 51, 6, pp. 1076-80
Rheumatology, 51, 1076-1080. Oxford University Press
Rheumatology, 51(6), 1076-1080. Oxford University Press
Rheumatology, 51, 1076-80
Contains fulltext : 109910.pdf (Publisher’s version ) (Closed access) OBJECTIVES: The provisional ACR/European League Against Rheumatism (EULAR) definition of remission in RA requires a score of 1 despite fulfilment of the remaining criteria (TJC28
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8ecb03d826ad29c4206c6ad852343e4
https://hdl.handle.net/2066/109910
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje